Autohypnosis and Cancerology

NCT03429296

NAINTERVENTIONAL

Groupe Hospitalier Mutualiste de Grenoble

120 participants

Started 2018-05-23 · Completed 2022-07-01

Status: Completed (as of 12-23-2025)

Conditions

Colorectal CancerBreast Cancer

Interventions

OTHER: Autohypnosis learning

Linked Papers (from SciSciNet-V2)

Total Papers49

Background

14

Result

0

Derived

0

Unknown

35

View on ClinicalTrials.gov

Total Citations Per Year

Brief Summary

Therapeutical hypnosis is proven to be an effective medical support to chemotherapy: it was shown that it can reduce the pain, anxiety, fatigue felt by the patient. Yet, hypnosis requires the presence of an hypnotherapist, which is why auto-hypnosis could be an efficient alternative to handle the side effects of chemotherapy. In this study, colorectal cancer and breast cancer patients are either taught auto-hypnosis or are taken in standard care for their chemotherapy. The life quality score (QLQC30) assessed during and after chemotherapies will determine if auto-hypnosis is a good medical support in chemotherapies' adverse effects management. The proven benefices of auto-hypnosis in the handling of the side effects of chemotherapies could improve the quality of life of cancer affected patients.

Sort by:

Background Papers28

Adjuvant Trastuzumab in HER2-Positive Breast Cancer

2,553 citations

Adjuvant Trastuzumab in HER2-Positive Breast Cancer

2,553 citations

Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials

1,884 citations

Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials

1,884 citations

Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer

1,470 citations

Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer

1,470 citations

Revised TN Categorization for Colon Cancer Based on National Survival Outcomes Data

Revised TN Categorization for Colon Cancer Based on National Survival Outcomes Data

Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008

Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008

Adjunctive self-hypnotic relaxation for outpatient medical procedures: A prospective randomized trial with women undergoing large core breast biopsy

Adjunctive self-hypnotic relaxation for outpatient medical procedures: A prospective randomized trial with women undergoing large core breast biopsy

Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: a pooled analysis of individual patient data from four randomised controlled trials

Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: a pooled analysis of individual patient data from four randomised controlled trials

Anticipatory nausea and vomiting due to chemotherapy

Anticipatory nausea and vomiting due to chemotherapy

The relationship between quality of life (EORTC QLQ-C30) and survival in patients with gastro-oesophageal cancer

The relationship between quality of life (EORTC QLQ-C30) and survival in patients with gastro-oesophageal cancer

Randomized Controlled Trial of a Cognitive-Behavioral Therapy Plus Hypnosis Intervention to Control Fatigue in Patients Undergoing Radiotherapy for Breast Cancer

Randomized Controlled Trial of a Cognitive-Behavioral Therapy Plus Hypnosis Intervention to Control Fatigue in Patients Undergoing Radiotherapy for Breast Cancer

Hypnosis for cancer care: Over 200 years young

Hypnosis for cancer care: Over 200 years young

Can changes in health related quality of life scores predict survival in stages III and IV colorectal cancer?

Can changes in health related quality of life scores predict survival in stages III and IV colorectal cancer?

Group interventions to reduce emotional distress and fatigue in breast cancer patients: a 9-month follow-up pragmatic trial

Group interventions to reduce emotional distress and fatigue in breast cancer patients: a 9-month follow-up pragmatic trial

Emerging gene-based prognostic tools in early breast cancer: First steps to personalised medicine

Emerging gene-based prognostic tools in early breast cancer: First steps to personalised medicine

Result Papers0

No result papers linked

Derived Papers0

No derived papers linked

Unknown Papers35

The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM

8,386 citations

Interpreting the significance of changes in health-related quality-of-life scores.

2,659 citations

Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon Carcinoma

2,226 citations

Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial

2,086 citations

Capecitabine Plus Oxaliplatin Compared With Fluorouracil and Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer

Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial

Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials

The Prognostic Significance of Patient-Reported Outcomes in Cancer Clinical Trials

2 years versus 1 year of adjuvant trastuzumab for HER2-positive breast cancer (HERA): an open-label, randomised controlled trial

6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial

Randomized consent designs for clinical trials: An update

A Randomized Clinical Trial of a Brief Hypnosis Intervention to Control Side Effects in Breast Surgery Patients

Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled Phase III Trial

Baseline quality of life predicts survival in patients with advanced colorectal cancer

Food and Drug Administration requirements for approval of new anticancer drugs.

Behavioral Intervention for Cancer Treatment Side Effects

Relation between tumor size, quality of life, and survival in patients with colorectal liver metastases.

Brief presurgery hypnosis reduces distress and pain in excisional breast biopsy patients

Does a patient’s self-reported health-related quality of life predict survival beyond key biomedical data in advanced colorectal cancer?

A randomized clinical trial of a brief hypnosis intervention to control venepuncture-related pain of paediatric cancer patients

What has been learned from measuring health-related quality of life in clinical oncology

Fatigue during breast cancer radiotherapy: An initial randomized study of cognitive–behavioral therapy plus hypnosis.

Molecular and protein markers for clinical decision making in breast cancer: Today and tomorrow

Quality of life evaluation in oncological clinical trials — the EORTC model

Hypnosis Decreases Presurgical Distress in Excisional Breast Biopsy Patients

Other Paradigms: Health-Related Quality of Life as a Measure in Cancer Treatment

Quality of life measures (EORTC QLQ-C30 and SF-36) as predictors of survival in palliative colorectal and lung cancer patients

ASCO-CAP Guidelines for Breast Predictive Factor Testing

Minimal important differences in the <scp>EORTC QLQ‐C30</scp> in patients with advanced cancer

Can patient satisfaction with quality of life predict survival in advanced colorectal cancer?

[Digestive cancers in France. Geographic distribution and estimation of national incidence].

[Evaluation of the quality of life in clinical research in cancerology].